AbbVie Inc. ABBV NYSE

AbbVie Inc. (ABBV) has shown moderate revenue growth over the past 3 years, expanding from $58.1B to $61.2B (average +1.9%/yr). Net income reached $4.2B, reflecting earnings decline at -24.1%/yr on average. The net profit margin is 6.9%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 83.7% (high), with a +13.7pp trend over the period. With a $372B market cap and MOAT composite score of 94/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (30/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 17-year history, the company was profitable in 17 of 17 years — a perfect long-term track record
• INCOME (45/100, Partial) — the company is profitable but margin is below 15%
• MOAT (94/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 61/100 with 3/7 criteria passed.